VetusLignum wrote:pedrodelavega wrote:VetusLignum wrote:But no, since it is a question of comparing, on a population made up of positive symptomatic cases,
- Ireland, with paracetamol at home, and hospitalization only in the event of respiratory failure => lethality = 6.7%
- IHU, with hospitalization (for most people, very short), and with HCQ + AZI => lethality = 0.55%
- Iceland: 0.54%
https://grapevine.is/news/2020/05/27/hy ... -200-uses/
First, among the positives in Iceland, there are 50% asymptomatic, which reduces the case fatality rate for symptomatic patients to around 1%.
Secondly, the Icelandic policy against the virus was so effective that the elderly were generally protected from infection, therefore the population (of symptomatic positives) is relatively young, and is therefore not comparable to that of the 'IHU or Ireland.
The graph I am showing compares to the Netherlands, which only tested those who had severe symptoms (as in France), so in the end, it does not prove much; and as I have not been able to find up-to-date statistics on positive cases by age group in Iceland, I am forced to give up this argument.
On the other hand, I found interesting information concerning the way in which they treated the symptomatic positives (around 950). They kept themselves informed of their health, and gave treatment to those whose symptoms began to worsen.
„Á sama tíma heldég að Covid-göngu¬deild¬in sem hef¬ur fylgt sjúk¬ling¬um eft¬ir heima hafi skilað mikl¬um ár¬angri. Göngu¬deild¬in hef¬ur tryggt góða yf¬ir¬sýn og eft¬ir¬lit með sjúk¬ling¬um í heima¬húsi. Þeir hafa svo kallað til sín fólk sem lýs¬ir versn¬andi líðan og ein¬kenn¬um og veitt meðferð á göngu-deild¬inni. Frá göngu¬deild¬inni hafa svo sjúk¬ling¬ar verið lagðir inn á sjúkra¬húsið ef þeir þarfn¬ast frek¬ari mats og meðferðar, í sam¬ræmi við verk¬ferla sem sett¬ir voru upp í aðdr far¬ald¬urs-ins, “seg¬ir Mart¬in."At the same time, I think the Covid outpatient department, which has been following patients at home, has been very successful. The outpatient department has ensured a good overview and supervision of patients in the home. They have then called themselves people who describe worsening feeling and symptoms and provided treatment at the outpatient ward. From Ambulatory have so patients have been admitted to the hospital if they require further assessment and treatment, in accordance with the procedures that were installed in anticipation of the epidemic, "says Martin.
https://www.mbl.is/frettir/innlent/2020 ... elikvarda/
Result: only 27 patients required intensive care, of which only 4 died (the other 6 died did not go through intensive care, for various reasons).
Now, what was the treatment of patients whose symptoms got worse?
Engin lyfjameðferð var til við veirusýkingunni en ýmislegt hafði verið prófað úti í heimi og ráðleggingar voru gefnar í samræmi við bestu þekkingu hvers tíma. Sýklalyfjameðferð, week Hafdi Verid mjög fjölbreytt á smitsjúkdómadeildinni hingað til fólst í í þessum faraldri eingöngu gjöf azithromycins lítillega og var af rocephalini week prófað fyrst um að gefa sjúklingum sinn er um bakteríulungnabólgu grunur var. hydroxychloroquine, sem var algengt gigtar- og malaríulyf, var prufað að nota á marga sjúklinga en vegna aukaverkana þurfti að fylgjast vel með einkennum frá hjarta og því voru sumir sjúklingar settir í „a. Tveir „monitorar“ voru fengnir á deildina í byrjun faraldurs. Einnig var þörf á að taka hjartalínurit við komu og daglega vegna þessara lyfja. Í dag hefur notkun þessara lyfja verið hætt vegna þess að engar rannsóknir hafa sýnt fram á virkni við covid.There was no drug treatment for the viral infection, but various things had been tested around the world and recommendations were given in accordance with the best knowledge of each time. Antibiotic therapy, which had been very diverse in the infectious disease ward to date, included this epidemic solely with
azithromycin administration and little of
rocephalin, which was first tested for the first time in patients suspected of bacterial pneumonia.
hydroxychloroquine, a commonly used anti-rheumatic and malaria drug, was used in many patients, but due to adverse reactions, cardiac symptoms had to be carefully monitored and therefore some patients were placed on monitora. Two "monitors" were hired at the ward at the beginning of the epidemic. There was also a need for cardio on arrival and daily for these drugs. Today, the use of these drugs has been discontinued because no studies have shown efficacy with covid.
https://www.hjukrun.is/library/Timarit- ... 2_2020.pdf
In your link, it says that less than 200 patients have received hydroxychloroquine; I believe this number fits the number of patients whose symptoms are expected to worsen statistically (this represents a little more than 20% of the symptomatic).
So, even if they stopped giving hydroxychloroquine (at a time when they had almost no more patients) following phony studies like that of Lancet, this treatment, nevertheless seems to have been one of the keys to their success.